Skip to content

Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda

Effectiveness of Intermittent Screening and Treatment of Malaria in Pregnancy (ISTp) on Maternal and Birth Outcomes in Selected Districts in Rwanda

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03508349
Enrollment
1786
Registered
2018-04-25
Start date
2016-09-05
Completion date
2019-03-18
Last updated
2019-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria in Pregnancy

Brief summary

The main aim of this study is to test the primary hypothesis that the addition of intermittent screening and treatment of malaria in pregnant women (ISTp) who receive routine antenatal care (ANC) in health facilities in high malaria transmission areas in Rwanda will reduce malaria prevalence among pregnant women when compared to routine antenatal cares services alone.

Detailed description

More specifically, the primary objective is to understand the effect of ISTp in a context where routine antenatal care does not include malaria chemoprohylaxis and whether this intervention is protective against malaria during pregnancy. The secondary objective is to determine whether this intervention results in an improvement in other key maternal and newborn health outcomes including maternal anemia, low birth weight and prematurity. The third objective is to determine the feasibility, effectiveness and acceptability of ISTp among women who receive ISTp and among health workers who deliver this intervention. This study will establish if testing and treating pregnant women is effective, feasible and whether it adds an additional burden to the work already being undertaken by facility-based health workers who provide antenatal care services. It is expected that the study will result in information to develop appropriate approaches that can be implemented in Rwanda in the prevention of malaria in pregnancy in addition to the use of preventive measures such as insecticide treated mosquito nets (ITNs) and case management. This information may potentially also be used by other countries with similar patterns of malaria transmission.

Interventions

DIAGNOSTIC_TESTIST

Women in the control group will receive routine care, which does not include testing for malaria with a rapid diagnostic test unless symptomatic for malaria. Women in the intervention group will receive this additional testing for malaria at each antenatal care, regardless of whether she is symptomatic for malaria.

Sponsors

Rwanda Malaria and Other Parasitic Diseases Division (MOPDD)
CollaboratorUNKNOWN
Centers for Disease Control and Prevention
CollaboratorFED
Jhpiego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

Health facilities in high malaria transmission zones were pair matched and then randomized to be an intervention or a control facility.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women age 18 or older who have their first ANC visit during the study recruitment period * Willing to participate

Exclusion criteria

* • Pregnant women below the age of 18 * Not willing to participate

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of placental malaria at delivery (tested by PCR)at the time of deliverycomparison of prevalence of malaria between women in intervention and control sites

Secondary

MeasureTime frameDescription
Prevalence of maternal anemia at deliveryat the time of deliverycomparison of prevalence of maternal anemia between women in intervention and control sites
Prevalence of low birth weight babies (<37 weeks gestation)at the time of deliverycomparison of prevalence of LBW between women in intervention and control sites
Prevalence of preterm birthsat the time of deliverycomparison of prevalence of preterm births between women in intervention and control sites
Episodes of clinical malaria during the course of the pregnancyassessed at the time of deliverydescription of the number of episodes of malaria detected during antenatal care visits during pregnancy

Other

MeasureTime frameDescription
Adverse outcome of pregnancy - abortions, still births and neonatal deathsassessed at the time of deliveryDescription of the number of adverse outcomes by group

Countries

Rwanda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026